公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2022 | Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: a real-world data analysis | HSIANG-FONG KAO ; HUAI-CHENG HUANG ; BIN-CHI LIAO ; RUEY-LONG HONG | BMC cancer | 2 | 2 | |
2023 | Traits of Patients With Pituitary Tumors in Multiple Endocrine Neoplasia Type 1 and Comparing Different Mutation Status | Lin, Kuan-Yu; YU-TING KUO ; MEI-FANG CHENG ; PEI-LUNG CHEN ; HSIU-PO WANG ; TSU-YAO CHENG ; CHIA-HSUIN CHANG ; HSIANG-FONG KAO ; SHIH-HUNG YANG ; HUNG-YUAN LI ; CHIA-HUNG LIN ; Chou, Yuh-Tsyr; Chung, An-Ko; WAN-CHEN WU ; JIN-YING LU ; CHIH-YUAN WANG ; Hsih, Wen-Hui; Wen, Chen-Yu; WEI-SHIUNG YANG ; SHYANG-RONG SHIH | The Journal of clinical endocrinology and metabolism | 0 | 0 | |
2014 | β-Catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma | LI-CHUN LU ; YU-YUN SHAO ; Lee Y.-H.; MIN-SHU HSIEH ; Hsiao C.-H.; Lin H.-H.; HSIANG-FONG KAO ; Ma Y.-Y.; Yen F.-C.; ANN-LII CHENG ; CHIH-HUNG HSU | Oncology (Switzerland) | 25 | 24 |